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Vascularization is essential for living tissue and remains a major challenge in
the field of tissue engineering. A lack of a perfusable channel network within
a large and densely populated tissue engineered construct leads to necrotic
core formation, preventing fabrication of functional tissues and organs. We
report a new method for producing a hierarchical, three-dimensional (3D)
and perfusable vasculature in a large, cellularized fibrin hydrogel. Bifurcat-
ing channels, varying in size from 1 mm to 200–250 mm, are formed using a
novel process in which we convert a 3D printed thermoplastic material into a
gelatin network template, by way of an intermediate alginate hydrogel. This
enables a CAD-based model design, which is highly customizable, reprodu-
cible, and which can yield highly complex architectures, to be made into a
removable material, which can be used in cellular environments. Our
approach yields constructs with a uniform and high density of cells in the
bulk, made from bioactive collagen and fibrin hydrogels. Using standard
cell staining and immuno-histochemistry techniques, we showed good cell
seeding and the presence of tight junctions between channel endothelial
cells, and high cell viability and cell spreading in the bulk hydrogel.1. Introduction
Aperfusable vascular network is necessary to support themass transport require-
ments of a metabolically active and highly populated tissue. The lack of a
three-dimensional (3D) system has held back progress into fabrication of complex
tissues and organs, as diffusion from the surface of a tissue construct becomes
unfeasible for rapid delivery of oxygen and nutrients [1]. A functioning blood
vessel network, which is 3D, hierarchical and perfusable, is thus a necessary
requirement of most functional tissues; the use of channel hierarchy enabling
both extensive coverage of the tissue while simultaneously providing the low
pressure heads required for efficient diffusion in and out of the bulk. Porous
materials, while improving the permeability of tissue engineered constructs, are
still limited in the capacity for this exchange in thick samples especially in scaf-
folds containing biologically relevant cell densities [2]. Additionally, blood
vessel infiltration by the host’s vasculature tends to be a slow process, meaning
limited functionality of implanted scaffolds [3]. Thus tissue engineering, which
seeks to fabricate new tissues and organs, requires approaches for the formation
of 3D vascular networks in materials suitable for supporting tissue development,
of which hydrogels are the most important group.
Current vascularization methods are limited in their capacity for supporting
a large volume and achieving full three-dimensionality; a variety of techniques
have been suggested for forming vascular systems, each with specific limit-
ations. Layer-by-layer approaches, such as those based on lithography, have
been reported [4–11] but are limited by the lack of three-dimensionality,
which is achievable from a single plane of channels. However, such approaches
do show that a perfusable vascular system greatly improves the functionality of
a tissue construct and can display characteristics of an active vascular system,
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hydrogel [4]. Gelatin and alginate have previously been used
as sacrificial materials for the formation of planar vascular net-
works, in which polydimethylsiloxane (PDMS) moulded casts
of hydrogel templates yielded perfusable networks at very fine
length-scales [9,12].
A range of direct 3D printing-based approaches have cre-
ated vascular networks in three-dimensions [13]. However,
they often require the casting material to be chemically or
photo-cross-linked, requiring cells to be seeded after casting
which leads to a lack of cell uniformity in the bulk of the
tissue construct, or they use materials that are synthetic in
origin and thus often have properties that limit cellular activi-
ties [14–16]. One promising sacrificial 3D printing technique
uses 3D filament networks of carbohydrate glass, allowing
casting in ideal tissue engineering materials, and which
generates open channels upon immersion in water [17].
However, there are issues with the cytotoxicity from the dis-
solution of carbohydrate glass templates (osmotic damage
to cells) and to prevent early degradation, the template
requires a synthetic coating (PLGA) [3]. Another promising
technique uses printing of Pluronic F127 as the sacrificial
material [18–21], which can be printed alongside cell-loaded
hydrogel materials.
The direct printing of these sacrificial materials limits the
complexity and structure of the vascular network that is pro-
ducible, due to certain properties of the materials (e.g.
hydrophilicity, gelling speed, removal method). For instance,
in the case of agarose [3] or carbohydrate glass printing [17], a
sequence of one-dimensional (1D) filaments is extruded out
of the printhead which touch at various locations to produce
network junctions. In the case of the carbohydrate glass, the
thickness of the channel is determined by the speed of the
printhead, limiting the structure of the finer features that
can be fabricated [17].
Other work has used thermoplastic 3D printed models to
produce internal channels in porous scaffolds, such as with
freeze-dried collagen [22,23] and PCL (collagen coating on
the channels) [24]. However, they require freezing and harsh
solvents as a means of formation of the scaffold and removal
of the channel template material. Thus, they must remain acel-
lular until after the process is completed and both approaches
require the collagen to be chemically cross-linked for stability.
Finally, 3D printed materials have recently been cast in PDMS
and removed to reveal a 1D helical channel (500 mm in diam-
eter) [25]. The use of PDMS as the bulk material limits the
use of cells to the channels only.
We have developed a novel process in which standard 3D
printed thermoplastic models, which are highly customizable
and reproducible, are converted into a gelatin hydrogel
material. This can then be used as a vascular network
template in highly bioactive hydrogel materials, which are
pre-loaded with cells. The ability to use 3D printed materials
in this way is achieved by casting an alginate intermediary,
which is ionically cross-linked with calcium, around the 3D
printed model. Alginate hydrogels are stable at high tempera-
tures (approx. 1008C), and do not decay in acetone, both of
which are required to remove the thermoplastic (polyester-
based) model in its entirety. By making use of the different
physical and chemical properties of the 3D printed material,
and of alginate and gelatin, we are able to selectively add and
remove positive and negative casts of the original network
design, resulting in a channelled construct made fromthermo-gelled collagen or enzymatically cross-linked fibrin
hydrogel. The use of gelatin gel as a vascular template has
the added advantage of enabling prompt perfusion once
the final construct has formed.
Recently, a 3D printed material has been converted into
an alginate template material and used in agarose and
genipin-cross-linked gelatin constructs, with trifurcating chan-
nel features down to 400 mm, supporting liver cancer cells
[26]. In our study, via a different set of materials, we produced
a bifurcating template, which was hierarchical in nature with
features down to 200 mm. The template material was remova-
ble within 20 min of casting, meaning minimal delay prior to
perfusion, which can be performed at physiologically
comparable rates. A flow rate of approximately 2 ml h–1
through the 200 mm channels can be achieved by applying
32 ml h–1 at the 1 mm inlet [17]. The implantable, bioactive
hydrogel materials collagen [27], as the major component of
extracellular matrix, and fibrin [28], as the major protein pre-
cursor for wound healing, were used as our final constructs.
These materials supported primary cells; here, we used endo-
thelial cells in the channels and connective tissue cells, which
showed spreading in the hydrogel constructs.2. Material and methods
2.1. Cell culture
Human umbilical vein endothelial cells (HUVEC, Public Health
England) and human dermal adult fibroblasts (HDFs, Public
Health England) were used for the experiments. The cells were
trypsinized using TrypLE Express (Life Technologies), centri-
fuged at 250 g for 5 min, and counted using a Scepter Cell
Counter (Millipore). HUVECs were cultured in a T75 flask to
80% confluence, using endothelial growth medium (no vascular
endothelial growth factor or platelet-derived growth factor)
(EGM Plus, Lonza), and HDFs were cultured in a T75 flask to
80% confluence using high-glucose Dulbecco’s modified Eagle’s
medium (Life Technologies) containing 10% fetal bovine serum
(FBS, Life Technologies).
HUVECs were imaged using Green Cell Tracker dye (Life
Technologies), allowing for immediate imaging and tracking of
cell seeding and distribution in the channels. Lyophilized fluor-
escent dye was resuspended in dimethyl sulfoxide (DMSO,
Sigma) at 10 mM and stored at 2208C until use. A working sol-
ution was prepared in DMEM at 10 mM. Plated cells were
washed with phosphate-buffered saline (PBS, Life Technologies)
and the working solution added. Flasks were incubated at 378C
for 45 min prior to trypsinization.
2.2. Three-dimensionally printed design and printing
The CAD model vasculature was designed using Autodesk
Inventor 2014 (figure 1a); the structure consists of a 1 mm inlet
which symmetrically bifurcates into a series of 200–250 mm
channels, which then converge into a single outlet of 1 mm.
Thermoplastic models in support wax were a gift from Solids-
cape UK. Models were fabricated using 12 mm layer thickness
and 10 base support layers, on a 3Z Studio printer. Following
printing, models in support wax were removed from the ceramic
base (8 mm) by placement on a hot plate at 1208C for 7 min.
Models in support wax could then be gently removed using
stiff card. To remove the support wax from the models
(figure 1b), they were put in a bath of selective solvent (BioAct
VSO, Solidscape) and placed in an oven at 558C for 4 h.
The model was subsequently stored in fresh solvent at room
temperature, until use (figure 1c).
1 mm1 mm5 mm
1 mm1 mm 1 mm
1 mm
1 mm
1 mm
12 mm
8.5 mm
0.2 mm
(a) (c) (d)(b)
(e) ( f ) (g) (h)
Figure 1. Process steps for converting CAD model into hydrogel channels. (a) CAD design, consisting of 1 mm inlet symmetrically bifurcating to sixteen 200–
250 mm channel features. Each of the finest channels is 2 mm in length. (b) Using a Solidscape 3D printer, models are produced in support wax. (c) Support
wax is removed using a selective solvent to reveal a high precision thermoplastic model. (d ) Schematic of custom-made silicone chamber; consisting of a silicone
sheet mounted on a glass imaging slide, thick-walled silicone tubing for chamber walls, flexible silicone tubing for inlets, and a CNC-milled silicone lid, which has
two holes for casting. Also shown is the 3D printed model from (a) for size comparison. (e) Model is mounted into silicone chamber. ( f ) Chamber is filled with
alginate hydrogel and a lid is fitted to the chamber. (g) Following model removal with heat and acetone, gelatin is infiltrated into the channels, and the alginate is
removed by chelation. (h) Gelatin template is cast in collagen (shown here) or fibrin hydrogel, which can be loaded with cells prior to gelation.
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The vascularized hydrogel was produced in a custom-made sili-
cone chamber. For the base, a 1 mm silicone sheet (Silex) was
adhered to a glass imaging slide (Fisher Scientific) and a section
of 12 mm internal diameter silicone tubing (VWR) attached to
this sheet, both using silicone sealant (Dow Corning). Two holes
were drilled on opposite sides of the chamber and flexible silicone
tubing with 1 mm internal diameter (VWR) fitted. A silicone lid
was made using a CNC milling machine from a 3 mm silicone
sheet (Silex), into which two 2 mm filling holes were drilled
(chamber design shown in figure 1d ). The models were briefly
dried on tissue paper and then very carefully placed between the
filled silicone inlets using tweezers. The inlets were rotated so as
to angle the model such that all channel features are visible
under an optical microscope at the same time (figure 1e). The
silicone inlets were then super-glued in place.2.4. Alginate preparation
Calcium alginate gels were prepared using an ‘internal setting’
method. This involved adding 300 mM CaHPO4 (Sigma) and
600 mM gluconolactone (Sigma) to 7.5% (w/v) sodium alginate
(Sigma). In order to prevent the trapping of bubbles between the
fine features of the 3D printed template, the chamber was first
filled with DI water. The viscous alginate precursor solution was
then slowly injected into the silicone chamber, displacing the
water and fully encapsulating the thermoplastic model. The gluco-
nolactone functions as an acidifier and causes the slow release of
calcium, enabling a controlled gelling mechanism and a uniformly
cross-linked hydrogel. The alginate gelwas left overnight at 48C for
maturation (figure 1f ).2.5. Model removal and gelatin template preparation
The model material was removed by placing the chamber in a
bath of near-boiling DI water. After 5 min, the liquid model
material was removed from the channels by gentle suction
with a 1 ml syringe. Following 10 min on ice, the channel struc-
ture was cleaned by injecting 2 ml of acetone into the channels to
purge any remaining model material. Subsequently, 6 ml of250 mM CaCl2 (Sigma) was injected around the network which
cross-links the surface of the alginate channels more thoroughly,
without causing significant syneresis.
Liquid gelatin (Sigma, porcine skin, low bloom, 15% (w/v),
pH 7.4) was infiltrated into the channel structure via suction. The
chamber lid was removed and the chamber placed in a bath con-
taining 200 mM sodium citrate (Sigma) and 200 mM glycine
(Sigma) to chelate the calcium cross-linking ions, and was then
left for 24 h at 48C, at which point the alginate was fully dissolved
into solution. Once the alginate gel had dissolved, the chamber
was placed in a bath of sterile, calcium free PBS to remove any
residual alginate in the chamber, and a lid attached under liquid,
which was then sealed using super-glue. The chambers were
finally purged of any remaining citrate or alginate by flowing
5 ml of PBS through the lid holes (figure 1g).2.6. Extracellular matrix hydrogel preparation
Collagen hydrogels were used at 7.5 mg ml–1 final concentration.
Soluble collagen solution was prepared using rat-tail tendon. We
solubilized the tendon using 0.1% (v/v) acetic acid on a magnetic
stirrer (250 ml g–1 tendon) for 60 h at 48C, and centrifuged the sol-
ution at 9000g for 90 min. The collagen was subsequently
lyophilized, weighed and resuspended at the required stock con-
centration in 0.1% (v/v) acetic acid. Collagen was gelled using a
standard approach [6], employing the addition of 10 M199
(Sigma), 1 M NaOH, and 0.2% (w/v) NaHCO3 (Sigma), in order
to raise the ionic content and pH of the collagen solution, thereby
inducing a gelling response. HDFs were carefully mixed into the
neutral precursor solution at 1  106 cells ml21, just prior to cast-
ing. Owing to the high viscosity of the collagen solution, it was
injected slowly on ice into the chamber using a syringe pump at
15 ml h–1, displacing the PBS supporting the gelatin template
(figure 1h). Following 20 min at room temperature, the chamber
was placed for an additional 20 min in a sterile 378C bath, which
rapidly gelled the collagen and melted the gelatin.
Fibrin hydrogels were produced using a final concentration
of 10–20 mg ml–1 bovine fibrinogen (Millipore) and 2 U ml–1
human plasma thrombin (Sigma). Lyophilized fibrinogen was
resuspended in pre-warmed 0.9% (w/v) NaCl at 60 mg ml–1
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Both were stored at 2208C until use. In total, 0.1 M NaOH was
added to the fibrinogen solution to raise the pH to 7.4. HDFs, in
cell medium, were carefully mixed into the precursor solution at
1  106 cells ml21 and thrombin was added just prior to casting.
The solution was subsequently loaded into a 1 ml syringe and
injected into the chamber via the lid holes, displacing the PBS
supporting the gelatin template. Following 5 min at room tempera-
ture, the chamber was placed in a sterile 378C bath for an
additional 15 min, which melted the gelatin.
2.7. Gelatin removal and channel seeding
Gelatin was removed from the channel network by gentle suction
of PBS at 378C through the inlets. Channels were checked for
patency using fluorescent 1 mm red tracer beads (Life Technol-
ogies). HUVECs were subsequently suspended in 100 ml of
endothelial growth medium and injected into the channels at
2  107 cells ml21. The chamber was left for 5 h-overnight prior
to commencing perfusion. Non-adherent HUVECs were flushed
from the channels and perfusion continued with endothelial
growth medium at 0.1 ml h–1 for 7 days, using a syringe
pump. For HDF experiments, high-glucose DMEM containing
10% FBS was perfused at a range of flow rates (1–30 ml h–1 at
the 1 mm inlet) for 7 days using a peristaltic pump, and the
medium reservoir was replaced every 2 days.
2.8. Characterization of microchannel formation
After 7 days of perfusion, the development of tight cell–cell junc-
tions between the channel HUVECs was determined using CD31
immunocytochemistry. Cells were fixed by injecting 4% (w/v)
paraformaldehyde (PFA) into the channels and leaving the
chamber at 48C for 1 h. Following three 5 min washes with PBS, a
permeabilizing solution containing 0.25% (v/v) Triton X-100
(Sigma) was injected into the channels for 10 min at room tempera-
ture, followed by a blocking solution of 1% bovine serum albumin
(BSA, Sigma) for 30 min at room temperature. The primary anti-
body, mouse monoclonal anti-CD31 (HEC7, Abcam), was added
at 1 : 100 in 1% BSA, injected through the inlet and incubated over-
night at 48C. Unbound antibodywas flushed out using three 5 min
washes of PBS, and a secondary antibody, goat anti-mouse IgG
H&L conjugated to AlexaFluor 568 (Abcam), was added at 1 : 200
in 1% BSA, injected into the channels, and incubated for 2 h in
the dark at room temperature. The unbound antibody was
subsequently flushed out using three 5 min washes of PBS.
Fluoroshield with 40,6-diamidino-2-phenylindole (DAPI, Life Tech-
nologies) was subsequently injected as a nuclear counterstain. Cell
viabilitywas performed using a Live–Dead kit (Life Technologies).
Fibrin gels containing 1  106 cells ml21 were cross-sectioned
through the centre of the construct, and the surface stained with
1 ml ml–1 calcein AM and 4 ml ml–1 ethidium homodimer-1.
After 20 min, slices were washed in PBS and imaged.
2.9. Imaging
Imaging was performed using phase contrast and epi-fluorescent
microscopy (Zeiss Observer.Z1 with ORCA-Flash4.0). Images
were processed using Zen software (Zeiss) and ImageJ. Other
images were taken using an overhead microscope (Olympus
SZX16 with PixeLINK camera and software), and also with an
optical camera (Canon Digital IXUS70).
2.10. Statistical analysis
Statistical analysis of live–dead data was performed using IBM
SPSS Statistics 23. Cells were manually counted using ImageJ
by taking representative sample areas of 1 mm2 (at least four
were analysed per flow rate). A Levene’s test showed varianceswere not homogeneous and so a comparison of values was car-
ried out using a Kruskal–Wallis and a Games–Howell post
hoc test. Differences were considered statistically significant for
p, 0.05. Data are presented as the mean+ s.d.3. Results and discussion
The channel network produced for this study has a hierarch-
ical structure, with channels bifurcating symmetrically from
1 mm to 200–250 mm, producing a single inlet and outlet,
and 16 channels to support a large 3D volume. 3D printed
models are prepared using a commercially available printer,
mounted into a custom-made silicone chamber, which is
filled with alginate gel. Following evacuation of the 3D
printed model material from the alginate cast, gelatin is sub-
sequently infiltrated into the channels and the alginate is
removed by chelation of the cross-linking calcium ions. This
template is then cast in a collagen or fibrin gel, which can
be pre-loaded with cells, and the gelatin liquefied at 378C.
The use of standard CAD and commercial 3D printing to
generate the first stages of the process conveys a high degree
of precision and reproducibility to the gelatin (figure 2a,b),
and thus the vascular channel structure. In particular, Solids-
cape inkjet technology enables very precise features to be
fabricated at significant volumes, and the use of support
wax enables a wide range of designs, including overhanging
features. Additionally, there is some choice in the shape of the
channel cross-section and the morphology of the channel
junctions. Thus, our approach enables gelatin templates to
be fabricated with a highly complex and fine network
architecture, which is fully scalable.
The CAD design in this study was influenced by a number
of considerations, including a correspondence to physiological
channel structures and fluidic conditions, but also to an ease of
handling and imaging. Vascular systems are constrained
physiologically by a number of relationships, most notably
Murray’s law relating parent and daughter branch diameters,
usually quoted as the sum of cubic terms which, among
other results, yields a constant shear force around the whole
network [29,30]. In this study, we have designed a network
that uses the sum of squared terms. If we were to follow the
sum of cubic terms, a higher number of bifurcations would
be needed and the same volume would have a much higher
density of channels. Mounting of the 3D printed models
requires an inlet size that is not difficult to handle; hence, we
used inlets with a diameter of 1 mm. For ease of imaging, a
template was desired with fewer channels such that there is
minimal overlap between them. The chamber is constrained
in this study to a volume of 1 ml in order to maximize cell con-
centration, though we postulate that much larger volumes are
possible as this is a casting-based technique, and thus a closer
proximity to Murray’s law is possible in the future.
The angles between parent and daughter branches are
chosen as 708, to minimize turbulent flow at junctions while
also maximizing the volume supported by the finest channels
of the network. The finest channels are 2 mm in length and are
separated by 1.5 mm in plane and 1 mmbetween planes. Thus,
these thoroughfare channels enable diffusion of nutrients and
oxygen into a significant proportion of the bulk hydrogel.
The choice of the gelatin and alginate used is essential for
this process to be successful. A low bloom (80 g) gelatin is
used that can withstand alginate removal and subsequent
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Figure 2. Fidelity of hydrogel channels and gelatin template to 3D printed model design. (a) Gelatin template without acetone wash, displaying three-dimension-
ality of the network. Note that without acetone wash, model material remains on the walls of the template. (b) Phase contrast image of gelatin template, displaying
minimal variation between individual features of the template. (c) Gelatin halo is formed around the desired template features when the alginate hydrogel is
insufficiently cross-linked or gelatin infiltration is undertaken at too high a temperature. Line denotes outer boundaries of gelatin halo and templated feature.
(d ) Comparison of the diameters of the templates finest features, at different stages of the fabrication process. The CAD model had finest features of size of
170 mm. Box plot displays minimum and maximum diameters, and 1st and 3rd quartiles. Circles represent median diameters. (e) Surface contours of gelatin
template display 12 mm thick terraces from layer-by-layer 3D printing process. Correspondence of 3D printed model ( f– i) to gelatin template ( j–m) for specific
large-scale features. (n) Tight interface between fibrin hydrogel and silicone inlet. Shown in red are 1 mm fluorescent beads, which do not leak around the side of
the inlets for a 20 mg ml–1 fibrin gel.
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low enough to be easily removed from the final hydrogel. It
is type A gelatin, which has a better gel strength to viscosity
ratio than type B [31]. A concentration of 15% (w/v) is suffi-
cient for the chelation and casting process, and has a melting
point such that a low viscosity liquid is produced upon melt-
ing at 378C. However, the gelatin template still requires
mechanical support from the surrounding liquid in order to
preserve its structure, prior to casting.
To enable the alginate to be cast and removed effectively,
a low viscosity sodium alginate is used at a concentration of
7.5% (w/v), which provides sufficient rigidity for the fabrica-
tion process; in particular resisting syneresis from high
temperatures, solvent exchange and CaCl2 addition. The algi-
nate gels are fabricated using an internal setting process
using CaHPO4 and gluconolactone as an acidifier, which
slowly releases the calcium producing a uniform alginate
hydrogel. Overloading the alginate gel with calcium at gela-
tion causes significant syneresis and thus poor reproduction
of the original CAD design. However, if extra calcium is
not added, the pore size of the alginate gel is sufficiently
large to allow the liquid gelatin to penetrate the surface of
the alginate gel. Following chelation, this generates a ‘halo’
of gelatin around the templated gelatin channels, greatly
increasing the diameter of the finest channels, as illustrated in
figure 2c. Additionally, themolecular weight of gelatin reduces
with increasing temperature [18] and thus using gelatin at
higher temperatures produces a thicker halo.
To overcome these issues, one must further cross-link the
channel surfaces of the alginate hydrogel by injecting CaCl2
via the inlets, and use gelatin at 378C. Sufficient cross-linking
of the alginate at the channel surface prevents the halo effectand produces channels close to the 3D printed model design.
In order that the injected calcium penetrates to the alginate
surface, the 3D printed model material must be completely
removed; a layer of model material prevents the calcium
from cross-linking the alginate sufficiently. To this end, the
remaining (polyester-based) model material is dissolved
using acetone once the channels have become patent. If
acetone is not used, the gelatin template is turbid and some
model material can be left on the surface (figure 2a). In
total, 250 mM CaCl2 is then injected around the channel net-
work, cross-linking the alginate channel surface but without
causing significant syneresis of the whole gel.
The choice of alginate as an intermediary casting medium
enables fine features of the network to be translated into the
gelatin network, though there is some variation between the
CAD design and the 3D printed model, between the model
and the gelatin template, and between the gelatin template
and hydrogel channels, as shown in figure 2d. As the 3D
printed models are produced with features at the lower
limit of the Solidscape machines, there is some variation in
their size; a CAD feature with a diameter of 170 mm yielded
a model with features in the range of 200–250 mm.
Using negative pressure, liquid gelatin can infiltrate the
channel network. If positive pressure is used instead, gelatin
infiltrates the interface between the alginate gel and silicone
chamber, and also coats the inlets, which prevents the fibrin
hydrogel fromadhering to the (hydrophobic) silicone chamber.
When the gelatin is liquefied, this opens leak paths around the
fibrin hydrogel. The alginate gel was chosen to withstand
the applied negative pressure without collapsing.
The thermoplastic model has in its surface 12 mm thick ter-
races due to the layer-by-layer nature of the 3D printing
( f )(a) (c)(b)
(e)(d)
500 mm 200 mm 200 mm
200 mm 200 mm
100 mm
Figure 3. (a) HUVECs, labelled with green Cell Tracker dye, were injected into the channels of 20 mg ml– 1 fibrin hydrogels at 2  107 cells ml21 and left over-
night, prior to perfusion at 0.1 ml h–1. (b–e) After 8 days, all four channel layers of the vascular network have high levels of seeded HUVECs. ( f ) CD31
immunostaining was performed on hydrogels containing HUVECs in the channels in order to determine the early formation of tight junctions between endothelial
cells. Shown here is a single channel lined with HUVECs, after 8 days of perfusion at 0.1 ml h– 1. Red and blue colours display cell– cell adhesion marker and nuclear
stain, respectively.
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shown in figure 2e, which demonstrates a high casting fidelity
of surface features. On a larger scale however, the overall chan-
nel structure is less well preserved due to the weakmechanical
properties of gelatin and the suction employed for its infiltra-
tion into the alginate channels. Additionally, there is a
notable change in the diameter of the gelatin features on vari-
ation of the volumes of acetone and CaCl2 injected into the
alginate channels, both of which produce at least some shrink-
age of the alginate gel, acting to reduce the volume of the
channels within. The result is channels finer than those
modelled in the CAD (figure 2d). However, as shown in
figure 2f–m, there is good correspondence between the 3D
printed model and gelatin template.
In this study, both fibrin and collagen hydrogels were
used to test the use of the gelatin template with ideal tissue
construct materials. Fibrin was easier to handle because at
20 mg ml–1, the precursor solution has low viscosity and
once thrombin has been added, can be cast quickly using a
1 ml syringe. Conversely, at concentrations of 7.5 mg ml–1,
collagen gel is much more viscous and requires slow casting
using a syringe pump. Collagen precursor solutions gel
rapidly at room temperature and so must be kept on ice
during this process.
The choice of bulk material was influenced by a need for
perfusion and thus a requirement for a tight interface to an
external pumping system; thus, silicone inlets were used. It
is well known that hydrophobic materials, such as silicone
and Teflon, have some protein-binding capacity [32]. In this
study, we rely on this adsorption of protein to the surface
of silicone rather than the use of other agents to directly
bond the gel at the interface. This interface, as shown in
figure 2n, was tested using fluorescent red 1 mm beads,
which showed minimal leaking around the silicone inlet sur-
face when used with fibrin gels. Further, perfusion was tested
up to 30 ml h–1 (at the inlet) with 10 mg ml–1 fibrin gels,
which showed no signs of leaking from the chamber.
The use of gelatin as the sacrificial template material has
the advantage that it is thermally removed at physiological
temperatures. This allows the cell-loaded constructs to be
immediately placed in incubator conditions and puts minimal
stress on the cells themselves. The use of gelatin enables awide
range of materials to be employed as the final cast, beyond
those of thermally cross-linked collagen and enzymaticallycross-linked fibrin hydrogels. The template is capable of with-
standing a viscous casting material, as shown by 7.5% (w/v)
collagen (figure 1h), which can be infiltrated without signifi-
cant displacement of the gelatin template, by way of slow
casting with a syringe pump. The release of the template con-
stituents upon thermal dissolution impacts minimally upon
the surrounding cellular environment due to the relatively
benign nature of gelatin. We postulate that the gelatin template
could be used with other hydrogels of relevance to the tissue
engineering field, such as alginate, hyaluronic acid, Matrigel,
synthetic materials such as PDMS, and also interpenetrating
polymeric networks.
As a preliminary evaluation of the vascular system, a series
of pilot cell experimentswas performed.HUVECswere seeded
into the channels via the inlets, as shown in figure 3a. HUVECs
spread evenly around the symmetrically bifurcating channels
and, after several hours, had adhered to the hydrogel channel
walls. After 8 days of perfusion, a higher number of HUVECs
was observed in all four channel levels of the template
(figure 3b–e). These cells were perfused at relatively low flow
rates (0.1 ml h–1) so as to not dislodge the cell layer in the initial
stages of the endothelium formation. Further, the observation
of high numbers of cells over all layers shows that flow is not
confined to a single layer and that nutrients and oxygen
would reach a fully 3D volume when cells are added to the
bulk. Immunocytochemistry for the cell adhesion marker
CD31 showed the formation of tight junctions between
HUVECs in the channels (figure 3f ).
To evaluate the ability of the channel network to support
cells in the bulk of the hydrogel, HDFs were mixed into the
fibrin precursor solution prior to gelation and cell-loaded
fibrin gels (10 mg ml–1) were perfused at a range of flow
rates (0.5–30 ml h–1). After 7 days, a live–dead viability
assay was performed by cross-sectioning the gel and staining
the central surface with calcein AM and ethidium homo-
dimer-1. There was a notable difference in the viability and
cell spreading in the constructs at different flow rates; good via-
bility of HDFs was observed in the bulk for flow rates above
10 ml h–1 and further showed increased cell elongation with
increasing flow rate, as shown in figure 4a–c. To quantify
any improvement in viability, live and dead cells were counted
in representative sample regions and plotted against flow rate,
as shown in figure 4d. Static conditions (non-perfused) or low
flow rates were incapable of supporting the metabolic
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Figure 4. To determine the ability to support cells in thick constructs, HDFs were encapsulated in 10 mg ml– 1 fibrin gels at 1  106 cells ml21 and perfused at a
range of flow rates. After 7 days, the gels were cross-sectioned and stained with calcein AM (green) and ethidium homodimer-1 (red). (a–c) Live–dead staining for
flow rates at which the majority of cells are viable. At 10 ml h– 1, most cells are round while at 30 ml h– 1, most cells are spread out. Shown is a cross-section
through the middle of the gel normal to the long axis of the channels. (d ) In order to quantify cell viability at different flow rates, the number of live and dead cells
were counted in sample regions. Static conditions (no perfusion) and low flow rates produced constructs with high numbers of dead cells and flow rates above
10 ml h– 1 produced constructs with high numbers of live cells (*p, 0.05, ***p , 0.001). Comparisons show a statistically significant difference between live cell
numbers for flow rates of 1 ml h– 1 and 10–30 ml h–1, and for those between 10 ml h– 1 and 30 ml h– 1.
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shown to be suitable for maintaining cell viability.
It is conceivable that with improvements in commercial 3D
printing technologies, models could be produced with higher
precision, smaller feature sizes, and in new materials with
improved mechanical, physical, and chemical properties. The
process described here, of converting these 3D printed
models into gelatin vascular templates, and subsequently cel-
lularized hydrogel materials, would utilize these advances.
Further, as we make use of standard 3D printing technology,
the fabrication method is relatively inexpensive in comparison
with other approaches, such as those requiring custom-made
printers, and so could be widely used for 3D network
formation in cellularized constructs.4. Conclusion
Current vascularization methods are limited in their capacity
for supporting a large construct volume and achieving full
three-dimensionality. We report a new method for producing
vasculature, which is hierarchical, 3D, and perfusable, in a
fully cellularized and bioactive hydrogel. Vascular networks
are created by converting 3D printed thermoplastic material
into gelatin which, importantly, can be used in cellularizedenvironments cast from extracellular matrix materials and
can be removed efficiently for prompt perfusion. We were
able to fabricate channels with diameters of 200 mm and
apply flow rates comparable with physiological conditions.
Further, the ability to use bioactive hydrogel materials with
our process enables the support of primary cells, displaying
tight cell junctions in the channels, and a high viability and
cell spreading in the bulk. These thick constructs are suitable
as an inexpensive platform for 3D cell studies and engineering
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